알코올성 간염 치료 시장 규모, 점유율, 성장 분석 : 치료 종류별, 약물 계열별, 질환 중증도별, 투여 경로별, 최종사용자별, 유통 채널별, 지역별 - 업계 예측(2026-2033년)

Global Alcoholic Hepatitis Treatment Market size was valued at USD 1.45 Billion in 2024 and is poised to grow from USD 1.55 Billion in 2025 to USD 2.62 Billion by 2033, growing at a CAGR of 6.8% during the forecast period (2026-2033).

The Global Alcoholic Hepatitis Treatment market encompasses pharmaceuticals and biologics designed to mitigate liver inflammation and thwart the progression to cirrhosis, driven by the escalating prevalence of alcohol-related liver disease, which contributes significantly to global liver mortality. Market growth is primarily fueled by increasing heavy-drinking trends in emerging economies, spurred by urbanization and rising disposable incomes. Recent advancements in corticosteroid-based therapies and agents such as obeticholic acid represent a shift from traditional palliative care to targeted pharmacotherapy. Additionally, AI-driven precision medicine is revolutionizing treatment by leveraging genomic and proteomic data, enabling personalized therapeutic pathways and fostering rapid hypothesis testing. This data-centric approach promotes investment in AI infrastructure and enhances patient selection, ultimately leading to improved therapeutic outcomes and market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Alcoholic Hepatitis Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Alcoholic Hepatitis Treatment Market Segments Analysis

Global alcoholic hepatitis treatment market is segmented by treatment type, drug class, disease severity, route of administration, end user, distribution channel and region. Based on treatment type, the market is segmented into Corticosteroid Therapy, Nutritional Therapy, Liver Transplantation, Supportive Care and Others. Based on drug class, the market is segmented into Corticosteroids, TNF-Alpha Inhibitors, Antioxidants, Hepatoprotective Agents and Others. Based on disease severity, the market is segmented into Mild Alcoholic Hepatitis, Moderate Alcoholic Hepatitis and Severe Alcoholic Hepatitis. Based on route of administration, the market is segmented into Oral and Injectable. Based on end user, the market is segmented into Hospitals, Specialty Liver Clinics and Transplant Centers. Based on distribution channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Alcoholic Hepatitis Treatment Market

The rising awareness among the public and healthcare professionals regarding alcoholic hepatitis has significantly increased the acknowledgment of its severity, leading to earlier interventions and a higher rate of patient referrals to specialized care facilities. Health campaigns and educational initiatives underscore the dangers of chronic alcohol consumption, motivating individuals to seek medical assessments at the first signs of symptoms. This enhanced visibility not only fuels the demand for effective treatment options but also influences physicians' prescribing patterns, resulting in greater market integration as an increasing number of patients qualify for both established and novel therapies, ultimately fostering ongoing market expansion.

Restraints in the Global Alcoholic Hepatitis Treatment Market

The high cost associated with advanced therapies poses a substantial obstacle to their widespread acceptance within various healthcare systems, especially those facing tight reimbursement constraints or inadequate insurance coverage. Insurance providers frequently impose strict utilization criteria on these costly treatments, which can result in delays or denials for patients, compelling them to utilize alternative options first. This financial pressure discourages healthcare professionals from opting for newer medications and leads patients to consider more affordable, yet potentially less effective, alternatives. As a result, the overall growth of the market is hindered, and manufacturers may struggle to realize their projected sales figures.

Market Trends of the Global Alcoholic Hepatitis Treatment Market

The Global Alcoholic Hepatitis Treatment market is increasingly embracing personalized therapeutic approaches, leveraging advancements in genetic profiling and biomarker identification to customize treatment regimens. Clinicians are prioritizing patient-specific drug combinations and dosing strategies that enhance efficacy while minimizing adverse effects. This trend has attracted significant investments from pharmaceutical developers in companion diagnostics and targeted agents, creating fruitful collaborations with academic institutions to translate cutting-edge research into clinical applications. This shift towards a patient-centered focus is set to transform therapeutic pathways, ultimately improving long-term outcomes for diverse patient populations across the globe, driving the market's growth and evolution.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Disease Epidemiology
• Pipeline Analysis

Global Alcoholic Hepatitis Treatment Market Size by Treatment Type & CAGR (2026-2033)

• Market Overview
• Corticosteroid Therapy
• Nutritional Therapy
• Liver Transplantation
• Supportive Care
• Others

Global Alcoholic Hepatitis Treatment Market Size by Drug Class & CAGR (2026-2033)

• Market Overview
• Corticosteroids
• TNF-Alpha Inhibitors
• Antioxidants
• Hepatoprotective Agents
• Others

Global Alcoholic Hepatitis Treatment Market Size by Disease Severity & CAGR (2026-2033)

• Market Overview
• Mild Alcoholic Hepatitis
• Moderate Alcoholic Hepatitis
• Severe Alcoholic Hepatitis

Global Alcoholic Hepatitis Treatment Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Oral
• Injectable

Global Alcoholic Hepatitis Treatment Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Specialty Liver Clinics
• Transplant Centers

Global Alcoholic Hepatitis Treatment Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Alcoholic Hepatitis Treatment Market Size & CAGR (2026-2033)

• North America (Treatment Type, Drug Class, Disease Severity, Route of Administration, End User, Distribution Channel)
  • US
  • Canada
• Europe (Treatment Type, Drug Class, Disease Severity, Route of Administration, End User, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Treatment Type, Drug Class, Disease Severity, Route of Administration, End User, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Treatment Type, Drug Class, Disease Severity, Route of Administration, End User, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Treatment Type, Drug Class, Disease Severity, Route of Administration, End User, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gilead Sciences, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bristol Myers Squibb Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Madrigal Pharmaceuticals, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Viking Therapeutics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Akero Therapeutics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genfit S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inventiva S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Galectin Therapeutics Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hepion Pharmaceuticals, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Durect Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations